Instil Bio, Inc. (TIL)

NASDAQ: TIL · IEX Real-Time Price · USD

0.405

-0.007 (-1.79%)

Sep 28, 2023, 9:30 AM EDT - Market open

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019
Revenue	0	0	0.14	0
Gross Profit	0	0	0.14	0
Selling, General & Admin	62.24	48.31	14.38	2.56
Research & Development	141.06	107.25	19.4	4.03
Other Operating Expenses	23.17	0	0	0
Operating Expenses	226.46	155.56	33.78	6.59
Operating Income	-226.46	-155.56	-33.64	-6.59
Interest Expense / Income	1.88	0	0	0
Other Expense / Income	-3.09	1.2	3.94	-0.06
Pretax Income	-225.25	-156.76	-37.59	-6.52
Income Tax	-2.07	0.04	0.15	0
Net Income	-223.18	-156.79	-37.74	-6.52
Shares Outstanding (Basic)	130	106	16	12
Shares Outstanding (Diluted)	130	106	16	12
Shares Change	22.19%	562.55%	35.04%	-
EPS (Basic)	-1.72	-1.48	-2.36	-0.55
EPS (Diluted)	-1.72	-1.48	-2.36	-0.55
Free Cash Flow	-264.75	-179.97	-80.43	-5.5
Free Cash Flow Per Share	-2.04	-1.70	-5.03	-0.47
Gross Margin	-	-	100.00%	-
Operating Margin	-	-	-24379.71%	-
Profit Margin	-	-	-27346.38%	-
Free Cash Flow Margin	-	-	-58284.06%	-
EBITDA	-215.62	-154	-37.33	-6.5
EBITDA Margin	-	-	-27051.45%	-
Depreciation & Amortization	7.75	2.75	0.26	0.02
EBIT	-223.37	-156.76	-37.59	-6.52
EBIT Margin	-	-	-27236.96%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).